Clinical Trials in Nashville

Showing 11161-11180 of 17,403 trials

Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery

NCT00952315

The investigators plan to compare three different devices that are used to break up large kidney stones during surgery for removal to see if one is faster or more efficient than the others.

Kidney Stones

Indiana Kidney Stone Institute270 participantsStarted Aug 2009

Phoenix, Arizona, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

NCT01072175

This was an open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK2118436 and GSK1120212 in combination. This study was designed in four parts. In Part A, the effect of repeat doses of GSK1120212 on the pharmacokinetics of single dose GSK2118436 was investigated prior to evaluating combination regimens. In Part B, the range of tolerated dose combinations was identified using a dose-escalation procedure. In Part C, different dose combinations of GSK2118436 and GSK1120212 were evaluated, based on results from the dose escalation cohorts. In Part D, the pharmacokinetics and safety of GSK2118436 administered as HPMC capsules alone and in combination with GSK1120212 was evaluated.

Cancer

Novartis Pharmaceuticals430 participantsStarted Mar 2010

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +12 more locations

Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery

Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

Find Trials by Condition in Nashville

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Healthy Weight Poster, Multi-site Study

An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

Radiofrequency Ablation in Treating Patients With Bone Metastases

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis

ATHENA: Natural History of Disease Study in Alport Syndrome Patients

Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors